World Cancer Day 2014 – Disease Review
World Cancer Day 2014 (4 February 2014) is a chance to raise our collective voices in the name of improving general knowledge around cancer and dismissing misconceptions about the disease (http://www.worldcancerday.org/). In celebration of this critical awareness day, Thomson Reuters is offering a series of free reports on a variety of different forms of cancer and treatments. Continue reading to review and download these insightful reports:
Spotlight On Chronic Myeloid Leukemia
With the advent of targeted therapy, chronic myeloid leukemia (CML) has undergone a major transformation from a terminal disease to an essentially manageable chronic condition. Despite significantly improved survival rates, there still remains room for improvement in efficacy, tolerability, and resistance potential.
Spotlight On Melanoma
The melanoma therapy market is currently experiencing an innovation breakthrough. Prior to 2011, patients with advanced melanoma were faced with poor prognosis and very limited treatment options, and the mainstay drugs DTIc (dacarbazine) and Proleukin were associated with poor response rates and a litany of toxicity issues.
Spotlight On Multiple Myeloma
Despite the therapeutic advances made over the last decade with the introduction of the immunomodulatory and proteasome inhibitor drug classes, multiple myeloma is still associated with a poor prognosis and has one of the lowest five-year survival rates in oncology. The disease remains incurable, and successfully maintaining remission is an uphill battle. Therapy is complicated by multiple settings and regimens, with a lack of long-term data from large-scale comparative trials to aid treatment choices.
Spotlight On Non-Small-Cell Lung Cancer
Over the past decade, a multitude of targeted agents have been explored in the treatment of non-small-cell lung cancer (NSCLC) and there are now three classes of agents which have been implemented in clinical practice.
Spotlight On Radiotherapeutics
The field of radiotherapeutics was, until recently, one where sales were considered lackluster. The difficulties inherent in making and administering drugs that are radioactive have often outweighed the clinical benefits of the early radiotherapeutics.
Find out more about World Cancer Day here.
Enjoyed this article? Subscribe to Life Sciences Connect for weekly email updates >>